IBRX
#1013
ImmunityBio, Inc. - Common Stock
8.0 5 USD
-0.04%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-4.17%
Variación mensual
+7.48%
Variación en los últimos 6 meses
-16.75%
Cambio anual
+244.02%
Cierres anteriores
8.4 0
Open
8.0 5
Mínimo
8.0 5
Máximo
8.0 5
Volumen
153
Financials
- Market Capitalization 8.53 B
- Employee 691
- Founded 2014
- CEO Rich Adcock
- Website www.immunitybio.com
- Headquarter Delaware, United States
- FIGI BBG007T9DYW9
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-9.03
Relación precio/flujo de caja
52.32
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 990 |  PCVX Vaxcyte, Inc. - Common Stock | 59.84 USD | -2.16% | -3.95% | +6.67% | +41.47% | 8.90 B USD | ||
| 992 |  ABVX Abivax SA - American Depositary Shares | 113.35 USD | -0.83% | -0.57% | -10.93% | +41.67% | 8.90 B USD | ||
| 1014 |  IMVT Immunovant, Inc. - Common Stock | 41.20 USD | -5.98% | -6.36% | +4.81% | +114.47% | 8.51 B USD | ||
| 1023 |  APGE Apogee Therapeutics, Inc. - Common Stock | 134.97 USD | +0.01% | +0.13% | +0.54% | +151.86% | 8.40 B USD |